(Q51192766)

English

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.

scientific article published in December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

0 references

3

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

author name string

Biedenbach DJ

1

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

Johnson DM

2

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

35

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

4

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

325-331

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of cefepime: a new extended-spectrum parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobact

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance of antibiotic resistance in South East Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900123-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(99)00123-6

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10668592

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51192766&oldid=2153639552"